SCHEMBL26100476

SCHEMBL26100476

O=C(O)c1c2c(nc3ccc(Cl)cc13)CCN(CCc1ccccc1)C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.56
▸ POLB P06746 3/20 0.56
▸ L3MBTL1 Q9Y468 3/20 0.56
▸ RECQL P46063 1/20 0.56
▸ CASP6 P55212 1/20 0.56
▸ ALDH1A1 P00352 7/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ PTPN2 P17706 1/20 0.46
▸ PTPN1 P18031 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ TSHR P16473 1/20 0.43
▸ CASR P41180 1/20 0.42
▸ LMNA P02545 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31666080 1.00 TDP1 (0.56) TDP1POLBL3MBTL1RECQLCASP6
SCHEMBL31666079 0.93 ALDH1A1 (0.48) TDP1POLBL3MBTL1RECQLCASP6
SCHEMBL26098464 0.93 ALDH1A1 (0.48) TDP1POLBL3MBTL1RECQLCASP6
SCHEMBL26098209 0.89 PLA2G2A (0.54) TDP1POLBL3MBTL1RECQLCASP6
SCHEMBL26099622 0.88 MAPT (0.56) TDP1POLBL3MBTL1ALDH1A1MAPK1
SCHEMBL26098455 0.87 ALDH1A1 (0.56) TDP1POLBL3MBTL1ALDH1A1MAPK1
SCHEMBL31666083 0.87 ALDH1A1 (0.56) TDP1POLBL3MBTL1ALDH1A1MAPK1
SCHEMBL26100377 0.86 LMNA (0.55) TDP1POLBL3MBTL1ALDH1A1MAPK1
SCHEMBL26098741 0.85 MAPT (0.53) TDP1POLBL3MBTL1ALDH1A1MAPK1
SCHEMBL26097544 0.84 MAPT (0.50) TDP1POLBL3MBTL1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139910-A1 COMPOSITIONS AND METHODS FOR TREATING MALARIA UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2023-05-04 — — US disclosed
US-20230139910-A1 COMPOSITIONS AND METHODS FOR TREATING MALARIA UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2023-05-04 — — US disclosed
US-20230139910-A1 COMPOSITIONS AND METHODS FOR TREATING MALARIA UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139910-A1 COMPOSITIONS AND METHODS FOR TREATING MALARIA G6PD, QDPR, FASN TDP1 3238/4885POLB 500/4885L3MBTL1 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback